Companies /Healthcare
Krystal Biotech Inc
NASDAQ: KRYS Biotechnology
$323.13
▼ $1.44 (−0.44%) today
Markets open · 11:38am ET

Krystal Biotech (KRYS) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
40%
EPS beat rate
+21.03%
Avg. EPS surprise
Consecutive EPS misses
KRYS vs Market · 30-day return after each reportKRYSS&P 500
−8%0%+8%+16%−1.8%+7.2%Q1 25+11.0%+2.8%Q2 25+12.2%+0.2%Q3 25−10.4%−3.4%Q4 25+18.1%+1.0%Q2 26
−8%0%+8%+16%Q1 25Q2 25Q3 25Q4 25Q2 26
KRYS EPS Trend · estimate vs actualEstimateActual
$0.00$0.80$1.60$2.40$1.52$1.20Q1 25$1.44$1.29Q2 25$1.12$2.66Q3 25$1.61$1.70Q4 25$1.91$1.79Q2 26
$0.00$0.80$1.60$2.40Q1 25Q2 25Q3 25Q4 25Q2 26
KRYS Revenue Trend · estimate vs actualEstimateActual
$0$40.0M$80.0M$120.0M$96.2M$88.2MQ1 25$92.0M$96.0MQ2 25$93.4M$97.8MQ3 25$105.1M$107.1MQ4 25$121.0M$119.2MQ2 26
$0$40.0M$80.0M$120.0MQ1 25Q2 25Q3 25Q4 25Q2 26

How Often Does Krystal Biotech Beat Earnings Estimates?

Krystal Biotech beat EPS estimates in 2 of its last 5 reported quarters.

KRYS quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $1.79 est. $1.91 −6.50% $119.2M est. $121.0M −1.50%
Q4 2025 $1.70 est. $1.61 +5.81% $107.1M est. $105.1M +1.88%
Q3 2025 $2.66 est. $1.12 +137.03% $97.8M est. $93.4M +4.69%
Q2 2025 $1.29 est. $1.44 −10.15% $96.0M est. $92.0M +4.44%
Q1 2025 $1.20 est. $1.52 −21.05% $88.2M est. $96.2M −8.34%

Figures from SEC filings and company reports. Not investment advice.